Shares of Aerie Pharmaceuticals surged 16.3% on Feb.
And just like that, stocks have landed back in the green. Following a several week long market performance that can only be described …
Aerie Pharmaceuticals (AERI) has a new bull. Esther Rajavelu of Oppenheimer initiates coverage of the biotech with an Outperform rating and a $64 …
No surprises within Rhopressa briefing documents – Good news for Aerie investors.
Dewey Steadman believes Aerie’s Rhopressa is in good standing for Friday’s AdCom.
After market close yesterday, Aerie Pharmaceuticals Inc (NASDAQ:AERI) announced positive 3-month top-line efficacy results from its pivotal phase III Mercury 2 trial for glaucoma eye …
Interpace Diagnostics Group Inc (NASDAQ:IDXG) shares rose nearly 8% in after-hours trading Wednesday, after the company announced that it is launching a new biomarker …
Aerie Pharmaceuticals Inc (NASDAQ:AERI) announced that it has entered into a lease agreement with the Industrial Development Agency (IDA) of Ireland for a …
Needham’s Serge Belanger has reiterated his Buy rating on Aerie Pharma (NASDAQ: AERI) despite a stalled manufacturing pre-inspection that has caused the firm to delay …
Dewey Steadman at research firm Canaccord has come out with a bullish call on shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI). The analyst assumed …
